SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 37.87+33.8%Nov 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mopgcw11/11/2005 2:39:40 AM
   of 566
 
Rigel files $200 million mixed shelf offering
Thu Nov 10, 2005 05:52 PM ET

WASHINGTON, Nov 10 (Reuters) - Rigel Pharmaceuticals Inc. (RIGL.O: Quote, Profile, Research) on Thursday said it may periodically sell up to $200 million in debt securities, common and preferred stock, warrants and units.
The company said in a shelf registration statement it plans to use the proceeds for research and development and general corporate purposes.

Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext